Literature DB >> 8748333

Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice.

N R Srinivas, W C Shyu, R S Weiner, L K Tay, D S Greene, R H Barbhaiya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8748333     DOI： 10.1002/jps.2600841217

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  9 in total

1.  Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.

Authors:  N R Srinivas; W C Shyu; R S Weiner; G Warner; C Comereski; L K Tay; D S Greene; R H Barbhaiya
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

2.  Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

Authors:  Yun Chen; Takahiro Fukuda; Monica S Thakar; Brian T Kornblit; Barry E Storer; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Journal:  Cytotherapy       Date:  2011-08-17       Impact factor: 5.414

3.  Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach.

Authors:  Hoi-Kei Lon; Dongyang Liu; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12       Impact factor: 2.745

4.  Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.

Authors:  Francesco Grassi; Gianluca Tell; Michaela Robbie-Ryan; Yuhao Gao; Masakazu Terauchi; Xiaoying Yang; Milena Romanello; Dean P Jones; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

5.  Neuroinflammation After Stereotactic Radiosurgery-Induced Brain Tumor Disintegration Is Linked to Persistent Cognitive Decline in a Mouse Model of Metastatic Disease.

Authors:  Chengyan Chu; Catherine M Davis; Xiaoyan Lan; Robert D Hienz; Anna Jablonska; Aline M Thomas; Esteban Velarde; Shen Li; Miroslaw Janowski; Mihoko Kai; Piotr Walczak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-05-26       Impact factor: 7.038

6.  Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis.

Authors:  Romana Meletta; Adrienne Müller Herde; Patrick Dennler; Eliane Fischer; Roger Schibli; Stefanie D Krämer
Journal:  EJNMMI Res       Date:  2016-01-04       Impact factor: 3.138

7.  Traumatic brain injury does not disrupt costimulatory blockade-induced immunological tolerance to glial-restricted progenitor allografts.

Authors:  Rui Wang; Chengyan Chu; Zhiliang Wei; Lin Chen; Jiadi Xu; Yajie Liang; Miroslaw Janowski; Robert D Stevens; Piotr Walczak
Journal:  J Neuroinflammation       Date:  2021-04-30       Impact factor: 8.322

8.  An immunocompetent mouse model of human glioblastoma.

Authors:  Samantha Semenkow; Shen Li; Ulf D Kahlert; Eric H Raabe; Jiadi Xu; Antje Arnold; Miroslaw Janowski; Byoung Chol Oh; Gerald Brandacher; Jeff W M Bulte; Charles G Eberhart; Piotr Walczak
Journal:  Oncotarget       Date:  2017-05-15

9.  Modeling human pediatric and adult gliomas in immunocompetent mice through costimulatory blockade.

Authors:  Xiaoyan Lan; Dorota A Kedziorek; Chengyan Chu; Anna Jablonska; Shen Li; Mihoko Kai; Yajie Liang; Miroslaw Janowski; Piotr Walczak
Journal:  Oncoimmunology       Date:  2020-06-05       Impact factor: 8.110
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.